Impact of 2018 Donor Heart Allocation Policy Change on Patients on Biventricular Support: A UNOS Database Analysis
Artificial Organs · 2026
DOI: 10.1111/aor.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2026. Verfasst von Daler Rahimov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Heart-Assist Devices, Tissue and Organ Procurement, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
In the United States, the donor heart allocation policy change in October 2018 granted high priority to patients on temporary mechanical circulatory support (MCS), positively influencing their pre‐transplant outcomes with reduced waitlist time. However, the impact of this policy change on patients requiring biventricular support remains undetermined.
Methods
We analyzed data from the United Network for Organ Sharing (UNOS) database from May 2013 to March 2024. Patients with biventricular assist devices (BiVADs), including temporary or durable devices, and total artificial hearts (TAHs) were included. The cohort was divided into two groups based on listing: before and after policy change groups. Waitlist and post‐transplant survival were compared between both groups.
Results
Patients on biventricular support comprised 1.5% (611/39 829) of all waitlisted candidates, and 2.6% (732/28 643) of all isolated heart transplants. There was a significantly lower prevalence of biventricular support after the policy change in both waitlisted candidates (Pre: 2.0% versus Post: 1.2%, p < 0.001) and at the time of transplantation (Pre: 3.1% versus Post: 2.1%, p < 0.001). Following the policy change, there was a significantly lower median waitlist time (Pre: 88 [29–190] days versus Post: 22 [7–69] days, p < 0.001), and a higher proportion of transplanted patients (Pre: 65% versus Post: 85%, p < 0.001). Both waitlist survival ( p < 0.001) and post‐transplant survival ( p = 0.05) improved after the policy change.
Conclusions
The 2018 policy revision was associated with a decline in biventricular support utilization in both waitlisted and transplanted cohorts. This shift corresponded with shorter waitlist durations, more frequent transplants, and better waitlist and post‐transplant survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiac Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Surgery, Bayhealth Medical Center, Dover, Delaware, USA.
- Division of Cardiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Daler Rahimov, T Reese Macmillan
Zitieren
APA
Rahimov, D., Nasher, N., Sakata, T., Macmillan, T. R., Pritting, C. D., Rame, J. E., Alvarez, R. J., Rajagopal, K., Entwistle, J. W., & Tchantchaleishvili, V. (2026). Impact of 2018 Donor Heart Allocation Policy Change on Patients on Biventricular Support: A UNOS Database Analysis. Artificial Organs. https://doi.org/10.1111/aor.70047
Vancouver
Rahimov D, Nasher N, Sakata T, Macmillan TR, Pritting CD, Rame JE, et al. Impact of 2018 Donor Heart Allocation Policy Change on Patients on Biventricular Support: A UNOS Database Analysis. Artificial Organs. 2026. doi:10.1111/aor.70047
BibTeX
@article{Rahimov2026,
author = {Rahimov, Daler and Nasher, Nayeem and Sakata, Tomoki and Macmillan, T Reese and Pritting, Christopher D and Rame, J Eduardo and Alvarez, Rene J and Rajagopal, Keshava and Entwistle, John W and Tchantchaleishvili, Vakhtang},
title = {Impact of 2018 Donor Heart Allocation Policy Change on Patients on Biventricular Support: A UNOS Database Analysis},
journal = {Artificial Organs},
year = {2026},
doi = {10.1111/aor.70047}
}
EUVIMED